Windlas Biotech Limited (NSE:WINDLAS)
India
· Delayed Price · Currency is INR 971.00
+14.80 (1.55%)
May 22, 2025, 3:29 PM IST
Windlas Biotech Revenue
Windlas Biotech had revenue of 1.95B INR in the quarter ending December 31, 2024, with 20.22% growth. This brings the company's revenue in the last twelve months to 7.28B, up 21.33% year-over-year. In the fiscal year ending March 31, 2024, Windlas Biotech had annual revenue of 6.31B with 22.97% growth.
Revenue (ttm)
7.28B
Revenue Growth
+21.33%
P/S Ratio
2.74
Revenue / Employee
6.31M
Employees
1,154
Market Cap
19.98B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 516.03B |
| Divi's Laboratories | 90.78B |
| Cipla | 271.45B |
| Mankind Pharma | 127.44B |
| Apollo Hospitals Enterprise | 211.46B |
| Zydus Lifesciences | 232.42B |
| Aurobindo Pharma | 309.22B |
| Alkem Laboratories | 127.57B |